Perforin affects regeneration in a mouse spinal cord injury model

References

• Popovich P, McTigue D. Damage control in the nervous system: beware the immune system in spinal cord injury. Nat Med. 2009;15(7):736–737.
   PubMed Web of Science ®Google Scholar
• Schwab JM, Zhang Y, Kopp MA, et al. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp Neurol. 2014;258:121–129.
   PubMed Web of Science ®Google Scholar
• Alizadeh A, Santhosh KT, Kataria H, et al. Neuregulin-1 elicits a regulatory immune response following traumatic spinal cord injury. J Neuroinflammation. 2018;15(1):53
   PubMed Web of Science ®Google Scholar
• Laliberte AM, Fehlings MG. The immunological response to spinal cord injury: helpful or harmful? Exp Neurol. 2013;247:282–285.
   PubMed Web of Science ®Google Scholar
• Beattie MS. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med. 2004;10(12):580–583.
   PubMed Web of Science ®Google Scholar
• Bechmann I. Failed central nervous system regeneration: a downside of immune privilege? Neuromolecular Med. 2005;7(3):217–228.
   PubMed Web of Science ®Google Scholar
• Bechmann I, Galea I, Perry VH. What is the blood-brain barrier (not)? Trends Immunol. 2007;28(1):5–11.
   PubMed Web of Science ®Google Scholar
• Ibarra A, Correa D, Willms K, et al. Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Brain Res. 2003;979(1–2):165–178.
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Zane K, Adams K, et al. The spinal cord-gut-immune axis as a master regulator of health and neurological function after spinal cord injury. Exp Neurol. 2020;323:113085
   PubMed Web of Science ®Google Scholar
• Schwartz M, Yoles E. Immune-based therapy for spinal cord repair: autologous macrophages and beyond. J Neurotrauma. 2006;23(3–4):360–370.
   PubMed Web of Science ®Google Scholar
• Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci. 2006;7(8):628–643.
   PubMed Web of Science ®Google Scholar
• Chan CC. Inflammation: beneficial or detrimental after spinal cord injury? Recent Pat CNS Drug Discov. 2008;3(3):189–199.
   PubMedGoogle Scholar
• Greenhalgh AD, Zarruk JG, Healy LM, et al. Peripherally derived macrophages modulate microglial function to reduce inflammation after CNS injury. PLoS Biol. 2018;16(10):e2005264.
   PubMed Web of Science ®Google Scholar
• Katsumoto A, Miranda AS, Butovsky O, et al. Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model. J Neuroinflammation. 2018;15(1):26.
   PubMed Web of Science ®Google Scholar
• Kopper TJ, McFarlane KE, Bailey WM, et al. Delayed azithromycin treatment improves recovery after mouse spinal cord injury. Front Cell Neurosci. 2019;13:490.
   PubMed Web of Science ®Google Scholar
• Trivedi A, Olivas AD, Noble-Haeusslein LJ. Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res. 2006;6(5):283–292.
   PubMed Web of Science ®Google Scholar
• Shinkai Y, Takio K, Okumura K. Homology of perforin to the ninth component of complement (C9). Nature. 1988;334(6182):525–527.
   PubMed Web of Science ®Google Scholar
• Henkart PA. Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 1985;3:31–58.
   PubMed Web of Science ®Google Scholar
• Liu CC, Persechini PM, Young JD. Perforin and lymphocyte-mediated cytolysis. Immunol Rev. 1995;146:145–175.
   PubMed Web of Science ®Google Scholar
• Voskoboinik I, Whisstock J, Trapani J. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15(6):388–400.
   PubMed Web of Science ®Google Scholar
• Backes CS, Friedmann KS, Mang S, et al. Natural killer cells induce distinct modes of cancer cell death: discrimination, quantification, and modulation of apoptosis, necrosis, and mixed forms. J Biol Chem. 2018;293(42):16348–16363.
   PubMed Web of Science ®Google Scholar
• Tschopp J, Nabholz M. Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol. 1990;8:279–302.
   PubMed Web of Science ®Google Scholar
• Shustov A, Luzina I, Nguyen P, et al. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J Clin Invest. 2000;106(6):R39–R47.
   PubMed Web of Science ®Google Scholar
• Miller NM, Shriver LP, Bodiga VL, et al. 2013. Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization. ASN Neuro. 2013;5(1):e00105.
   Google Scholar
• Deb C, Lafrance-Corey RG, Zoecklein L, et al. Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis. J Neuropathol Exp Neurol. 2009;68:1037–1048.
   PubMed Web of Science ®Google Scholar
• Deb C, Lafrance-Corey RG, Schmalstieg WF, et al. CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. PLoS One. 2010;5(8):e12478.
   PubMed Web of Science ®Google Scholar
• Hao J, Liu R, Piao W, et al. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med. 2010;207(9):1907–1921.
   PubMed Web of Science ®Google Scholar
• Peng SP, Zhang Y, Copray S, et al. Participation of perforin in mediating dopaminergic neuron loss in MPTP-induced Parkinson's disease in mice. Biochem Biophys Res Commun. 2017;484(3):618–622.
   PubMed Web of Science ®Google Scholar
• Mracsko E, Liesz A, Stojanovic A, et al. Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental stroke. J Neurosci. 2014;34(50):16784–16795.
   PubMed Web of Science ®Google Scholar
• Huggins MA, Johnson HL, Jin F, et al. Perforin expression by CD8 T cells is sufficient to cause fatal brain edema during experimental cerebral malaria. Infect Immun. 2017;85:pii:e00985–16
   PubMed Web of Science ®Google Scholar
• Johnson HL, Willenbring RC, Jin F, et al. Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. PLoS One. 2014;9(10):e111401.
   PubMed Web of Science ®Google Scholar
• Suidan GL, McDole JR, Chen Y, et al. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One. 2008;3(8):e3037.
   PubMed Web of Science ®Google Scholar
• Willenbring RC, Jin F, Hinton DJ, et al. Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption. J Neuroinflammation. 2016;13(1):222.
   PubMed Web of Science ®Google Scholar
• Wu B, Matic D, Djogo N, et al. Improved regeneration after spinal cord injury in mice lacking functional T- and B-lymphocytes. Exp Neurol. 2012;237(2):274–285.
   PubMed Web of Science ®Google Scholar
• Mehanna A, Jakovcevski I, Acar A, et al. Polysialic acid glycomimetic promotes functional recovery and plasticity after spinal cord injury in mice. Mol Ther. 2010;18(1):34–43.
   PubMed Web of Science ®Google Scholar
• Curtis R, Green D, Lindsay RM, et al. Up-regulation of GAP-43 and growth of axons in rat spinal cord after compression injury. J Neurocytol. 1993;22(1):51–64.
   PubMedGoogle Scholar
• Basso DM, Fisher LC, Anderson AJ, et al. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 2006;23(5):635–659.
   PubMed Web of Science ®Google Scholar
• Apostolova I, Irintchev A, Schachner M. Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J Neurosci. 2006;26(30):7849–7859.
   PubMed Web of Science ®Google Scholar
• Irintchev A, Rollenhagen A, Troncoso E, et al. Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cereb Cortex. 2005;15(7):950–962.
   PubMed Web of Science ®Google Scholar
• Jakovcevski I, Wu J, Karl N, et al. Glial scar expression of CHL1, the close homolog of the adhesion molecule L1, limits recovery after spinal cord injury. J Neurosci. 2007;27(27):7222–7233.
   PubMed Web of Science ®Google Scholar
• Vulovic M, Divac N, Jakovcevski I. Confocal synaptology: synaptic rearrangements in neurodegenerative disorders and upon nervous system injury. Front Neuroanat. 2018;12:11.
   PubMed Web of Science ®Google Scholar
• Djogo N, Jakovcevski I, Müller C, et al. Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice. Neurobiol Dis. 2013;56:104–115.
   PubMed Web of Science ®Google Scholar
• Lieberoth A, Splittstoesser F, Katagihallimath N, et al. Lewis(x) and alpha2,3-sialyl glycans and their receptors TAG-1, contactin, and L1 mediate CD24-dependent neurite outgrowth. J Neurosci. 2009;29(20):6677–6690.
   PubMed Web of Science ®Google Scholar
• Saini V, Loers G, Kaur G, et al. Impact of neural cell adhesion molecule deletion on regeneration after mouse spinal cord injury. Eur J Neurosci. 2016;44(1):1734–1746.
   PubMed Web of Science ®Google Scholar
• Bradbury EJ, Burnside ER. Moving beyond the glial scar for spinal cord repair. Nat Commun. 2019;10(1):3879.
   PubMed Web of Science ®Google Scholar
• Chen J, Leong SY, Schachner M. Differential expression of cell fate determinants in neurons and glial cells of adult mouse spinal cord after compression injury. Eur J Neurosci. 2005;22(8):1895–1906.
   PubMed Web of Science ®Google Scholar
• Puentes F, Van Der Star BJ, Victor M, et al. Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2013;10:118.
   Google Scholar
• Fouad K, Pearson K. Restoring walking after spinal cord injury. Prog Neurobiol. 2004;73(2):107–126.
   PubMed Web of Science ®Google Scholar
• Kleene R, Loers G, Jakovcevski I, et al. Histone H1 improves regeneration after mouse spinal cord injury and changes shape and gene expression of cultured astrocytes. Restor Neurol Neurosci. 2019;37(4):291–313.
   PubMed Web of Science ®Google Scholar
• Zagoraiou L, Akay T, Martin JF, et al. A cluster of cholinergic premotor interneurons modulates mouse locomotor activity. Neuron. 2009;64(5):645–662.
   PubMed Web of Science ®Google Scholar
• Miles GB, Hartley R, Todd AJ, et al. Spinal cholinergic interneurons regulate the excitability of motoneurons during locomotion. Proc Natl Acad Sci USA. 2007;104(7):2448–2453.
   PubMed Web of Science ®Google Scholar
• Guseva D, Jakovcevski I, Irintchev A, et al. Cell adhesion molecule close homolog of L1 (CHL1) guides the regrowth of regenerating motor axons and regulates synaptic coverage of motor neurons. Front Mol Neurosci. 2018;11:174.
   PubMed Web of Science ®Google Scholar
• Mehanna A, Szpotowicz E, Schachner M, et al. Improved regeneration after femoral nerve injury in mice lacking functional T- and B-lymphocytes. Exp Neurol. 2014;261:147–155.
   PubMed Web of Science ®Google Scholar
• Witts EC, Zagoraiou L, Miles GB. Anatomy and function of cholinergic C bouton inputs to motor neurons. J Anat. 2014;224(1):52–60.
   PubMed Web of Science ®Google Scholar
• Yokota K, Kubota K, Kobayakawa K, et al. Pathological changes of distal motor neurons after complete spinal cord injury. Mol Brain. 2019;12(1):4.
   PubMed Web of Science ®Google Scholar
• Bessis A, Béchade C, Bernard D, et al. Microglial control of neuronal death and synaptic properties. Glia. 2007;55(3):233–238.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Sun D, Rittling SR, et al. Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. J Neurosci. 2007;27(13):3603–3611.
   PubMed Web of Science ®Google Scholar
• Streit WJ. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia. 2002;40(2):133–139.
   PubMed Web of Science ®Google Scholar
• David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci. 2011;12(7):388–399.
   PubMed Web of Science ®Google Scholar
• Jones LL, Tuszynski MH. Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J Neurosci. 2002;22(11):4611–4624.
   PubMed Web of Science ®Google Scholar
• Gwak YS, Kang J, Unabia GC, et al. Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats. Exp Neurol. 2012;234(2):362–372.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang H, Xia H, et al. CD8 T cell-derived perforin aggravates secondary spinal cord injury through destroying the blood-spinal cord barrier. Biochem Biophys Res Commun. 2019;512(2):367–372.
   PubMed Web of Science ®Google Scholar
• Beck KD, Nguyen HX, Galvan MD, et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 2010;133(Pt 2):433–447.
   PubMed Web of Science ®Google Scholar
• Chun-Yan G, Bo H, Hong C, et al. Anti-perforin neutralizing antibody reduces myocardial injury in viral myocarditis. Cardiol Young. 2009;19(6):601–607.
   PubMed Web of Science ®Google Scholar